Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L MacInnis

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2022
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University PopulationsBrittany A Petros, Jacquelyn Turcinovic, Nicole L Welch, et al.
Plos Biology|February 12, 2020
Combining genomics and epidemiology to track mumps virus transmission in the United StatesShirlee Wohl, Hayden C Metsky, Stephen F Schaffner, et al.
Medrxiv : the Preprint Server for Health Sciences|December 4, 2023
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacyMichal Juraska, Angela M Early, Li Li, et al.
The Lancet. Infectious Diseases|May 9, 2024
Genotypic analysis of RTS,S/AS01<sub>E</sub> malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trialMichal Juraska, Angela M Early, Li Li, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
The New England Journal of Medicine|October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Cell Reports. Medicine|April 28, 2022
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
Nature Medicine|February 7, 2022
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variantsNicole L Welch, Meilin Zhu, Catherine Hua, et al.
Science (New York, N.Y.)|December 11, 2020
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading eventsJacob E Lemieux, Katherine J Siddle, Bennett M Shaw, et al.
Nature Medicine|November 9, 2023
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variantsNicole L Welch, Meilin Zhu, Catherine Hua, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2022
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University PopulationsBrittany A Petros, Jacquelyn Turcinovic, Nicole L Welch, et al.
Plos Biology|February 12, 2020
Combining genomics and epidemiology to track mumps virus transmission in the United StatesShirlee Wohl, Hayden C Metsky, Stephen F Schaffner, et al.
Medrxiv : the Preprint Server for Health Sciences|December 4, 2023
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacyMichal Juraska, Angela M Early, Li Li, et al.
The Lancet. Infectious Diseases|May 9, 2024
Genotypic analysis of RTS,S/AS01<sub>E</sub> malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trialMichal Juraska, Angela M Early, Li Li, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
The New England Journal of Medicine|October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Cell Reports. Medicine|April 28, 2022
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
Nature Medicine|February 7, 2022
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variantsNicole L Welch, Meilin Zhu, Catherine Hua, et al.
Science (New York, N.Y.)|December 11, 2020
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading eventsJacob E Lemieux, Katherine J Siddle, Bennett M Shaw, et al.
Nature Medicine|November 9, 2023
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variantsNicole L Welch, Meilin Zhu, Catherine Hua, et al.
Pageof 7